FINTRIX 250MG TAB

About

Terbinafine, the active ingredient in FINTRIX 250MG TAB, is an antifungal medication belonging to the allylamine class, primarily indicated for the treatment of dermatophyte infections affecting the skin, hair, and nails. Its fungicidal mechanism involves the selective inhibition of squalene epoxidase, a crucial enzyme in the fungal ergosterol biosynthesis pathway. This inhibition leads to a significant accumulation of squalene within the fungal cell and a concomitant deficiency of ergosterol, both of which are highly toxic to the fungal cell membrane. The resulting disruption in membrane integrity and function ultimately leads to fungal cell death. Terbinafine demonstrates potent efficacy against dermatophytes such as Trichophyton, Microsporum, and Epidermophyton species, which are the common causative agents of conditions like ringworm, athlete's foot, and onychomycosis. Its fungicidal nature often allows for shorter and more effective treatment courses compared to fungistatic agents, particularly for stubborn nail infections.

Uses

• Treatment of onychomycosis (fungal nail infections)
• Management of tinea corporis (ringworm)
• Therapy for tinea cruris (jock itch)
• Treatment of tinea pedis (athlete's foot)

Directions For Use

Take one tablet orally once daily with or without food, as directed by your doctor. Complete the full course of treatment even if symptoms improve.

Benefits

• Highly effective against dermatophytes
• Fungicidal action
• Shorter treatment durations for some infections
• Good penetration into skin and nails
• Available in oral and topical forms
• Relieves itching and discomfort

Side Effects

• Headache
• Diarrhea
• Nausea
• Abdominal pain
• Dyspepsia
• Rash
• Urticaria
• Taste disturbance (dysgeusia)
• Arthralgia (joint pain)
• Myalgia (muscle pain)
• Liver enzyme elevations (rarely severe)
• Fatigue

Safety Measures

• Alcohol - Avoid or limit alcohol consumption as it can increase the risk of liver side effects, which are a known concern with terbinafine.
• Pregnancy - Generally not recommended during pregnancy unless the potential benefits outweigh the risks, as animal studies show some risk.
• Breastfeeding - Terbinafine is excreted in breast milk; therefore, it is not recommended for use during breastfeeding.
• Liver - Contraindicated in patients with chronic or active liver disease. Liver function tests should be performed before and during treatment.
• Kidney - Use with caution in patients with renal impairment (creatinine clearance <50 mL/min); dose reduction may be necessary.
• Lung - No specific contraindications related to lung conditions.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.